Brevibacterium casei bacteraemia in a port-a-cath carrier patient: a case report

Infez Med. 2018 Sep 1;26(3):263-265.

Abstract

Brevibacteria are part of the normal flora of the skin and adjacent structures, but have been increasingly encountered in humans as opportunistic pathogens and have been isolated from various clinical specimens, generally causing infections in immuno-compromised patients. We present a case of a port-a-cath-related bacteraemia caused by Brevibacterium casei in a woman with a prior history of bilateral breast cancer. The clinical outcome was favourable.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / etiology
  • Bacteremia / microbiology*
  • Breast Neoplasms / therapy
  • Brevibacterium / drug effects
  • Brevibacterium / isolation & purification*
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / etiology
  • Catheter-Related Infections / microbiology*
  • Combined Modality Therapy
  • Cross Infection / drug therapy
  • Cross Infection / etiology
  • Cross Infection / microbiology*
  • Device Removal
  • Equipment Contamination
  • Female
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / etiology
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Linezolid / therapeutic use
  • Middle Aged
  • Neoplasms, Multiple Primary / therapy
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology
  • Opportunistic Infections / microbiology*
  • Teicoplanin / therapeutic use
  • Vascular Access Devices / adverse effects
  • Vascular Access Devices / microbiology*

Substances

  • Anti-Bacterial Agents
  • Teicoplanin
  • Linezolid